PressWhat’s news at AbelsonTaylor
Press Release
18 May

ELITE 2021 Creative Director Noah Lowenthal of AbelsonTaylor

For immediate release from PM360:

Noah Lowenthal

SVP, Group Creative Director

AbelsonTaylor

The Scientific Artist

In many ways, Noah Lowenthal shares the same creative DNA as Leonardo da Vinci. As a teenager, Noah was an artist with a scientific mind who understood the ability of art to communicate complex information in a way that that can be widely understood. Emulating the man credited with being the world’s greatest medical illustrator, Noah became one too. In fact, he is one of only a few thousand trained medical illustrators in the entire world today.

Noah has used his creative talents in his 21 years with AbelsonTaylor to consistently help clients attain their business goals by creating dynamic, multichannel marketing solutions for a broad range of brands in a wide variety of therapeutic categories. He has developed creative strategies for 20 successful product launches (nine of them global), including the Vertex drug Incivek, which was the first brand to reach $1 billion in sales in less than a year (it met the number in just nine months). He also has 50 successful relaunches to his credit and has maintained a 70% win rate on new business pitches since 2013.

Under his creative leadership, Noah and his teams have won numerous national and global awards, including three campaigns that have since been inducted into the Medical Advertising Hall of Fame: the Tarceva “Lifelines” campaign for Genentech/Roche Pharmaceuticals and the Rozerem launch website and Dexilant convention exhibit, both for Takeda.

Noah is also always exploring new communication channels and opening the door to new ways of generating ideas. Along with colleagues Mitch Apley and Joel Witmer, he helped develop an original AbelsonTaylor video content channel called Icons.Health. Shot at gatherings such as SXSW and the Cannes Lions International Festival of Creativity, Icons.Health explores innovation at the intersection of healthcare and technology via impromptu musings by innovators from a diverse range of organizations including Microsoft, Aetna, Twitter, IBM, and dozens of startups.

Operationally, he also seeks to find ways to reimagine AbelsonTaylor’s service offerings. He founded dose, the agency’s in-house studio that specializes in high-tech animation, online videos, and film/video production—and has generated substantial incremental revenue for the agency.